Project Grant HT94252510585
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$2.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This $3,150,000 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) will fund a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The award was granted to The University of Texas Health Science Center at San Antonio, a Hispanic-serving academic medical institution with extensive...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $2,346,267 to the University of Texas Health Science Center at Houston (UTHealth) to evaluate a technology-enhanced, entirely remote 2-week integrated treatment for pain and post-traumatic stress disorder (PTSD). The research project, titled "Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced Entirely Remote 2-Week Integrated...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
This federal Project Grant award of $2,398,281.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program aims to increase access to evidence-based PTSD treatment for military service members and veterans through Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary awardee, Palo Alto Veterans Institute for Research (Pavir), will oversee the overall project objectives, which include providing WET training to...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
This Project Grant award, valued at $4,208,345.00 and effective from September 30, 2024 to September 29, 2028, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports a "Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD" at the Regents of the University of Minnesota, a prominent land-grant research institution. This medical research project aims to...
The University of Arizona was awarded a $745,766.00 Project Grant under the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a randomized clinical trial on the use of psychiatric service dogs and prolonged exposure therapy for PTSD in military-connected populations. The award has a performance period from September 30, 2024 to September 28, 2025. As a subrecipient, the Lowcountry Center For Veterans Research will provide research support...